Viagra 100 mg (Sildenafil – Tablets)
What we hold on this line.
Brand
Viagra — maker's own packaging, as published.
Lab reports
No third-party COA held for this row — verification pending, nothing implied.
Questions we get about this line.
Who makes Viagra 100 mg (Sildenafil – Tablets)?
Viagra. It reaches you in their own sealed packaging, exactly as it reaches us — we resell, we do not repack, relabel or synthesise.
What is in one unit?
One unit is 10 tabs, as the maker states it. The price on this page is for that pack.
Who wrote the description above?
The maker, and what they publish for this line is unusually short. We print what they wrote rather than filling the gap ourselves; the specification, the pack and the paperwork below are the parts we can stand behind.
Is there a lab report for this?
Viagra publishes no lab report for this line, so this page carries none — we would rather leave the section empty than print a certification we cannot back. Where a report does exist, it is published on the product page it belongs to, under Batch documentation, with the lab, the batch, the measured values and the verification key you can check at the lab. For this line, send us your order number and the batch printed on your box and we request that batch's paperwork from Viagra.
How does it ship, and how fast?
Payment clearing on a working day means it is picked and posted the same day, and most boxes land in about 4 days, tracked, inside the European Union, in a plain carton. One flat €20.00 per order. Nothing travels refrigerated — the makers specify room temperature.
Can I send it back?
Unopened, seals intact, within 14 days of delivery, at your postage cost. Opened or reconstituted cannot come back — nobody can verify what is in an opened pack or how it was kept.
What is this sold for?
In-vitro laboratory research, and nothing else. Not for human or veterinary use; nothing on this page is medical advice, a dosing protocol or a recommendation.
On the label.
| Dose | 10 tabs |
| Form | TABLET |
| SKU | VIA-SD-041 |
| Category | ED & Vitality |
| Department | PHARMA |
| Manufacturer | Viagra |
What buyers said.
No reviews on this line yet. If you have worked with it, yours is the first.
From the research desk.
PharmaSildenafil in diabetes: the erectile endpoint that moved, and the glycaemic one that did not
Two randomised trials, two different questions. In 219 men with type 2 diabetes, sildenafil moved the erection questions of the IIEF from 1.86 and 1.84 to 3.42 and 3.35 out of 5, and held that gain whether HbA1c was above or below 8.3%. In 42 people with prediabetes, sildenafil 25 mg three times daily for 3 months improved the clamp insulin-sensitivity index by 1.84 — with a 95% CI from 0.01 to 3.67 and p = 0.049.
Claims we checkedPDE5 inhibitors and the heart: 1.25 million person-years
A 2024 meta-analysis of 16 cohorts with 1,257,759 subjects finds major adverse cardiovascular events at RR 0.78 and all-cause mortality at RR 0.70 for PDE5 inhibitor users. The randomised data in the same literature are null or uninterpretable: MACE RR 3.47 with a confidence interval of 0.17 to 69.19 in the diabetic subgroup, and no difference in pulmonary hypertension. This page reads both halves.
PharmaPDE5 inhibitors and exercise: what the trials measured
Sildenafil reliably lowers pulmonary artery pressure in hypoxia and reliably does not improve performance: 14 trials, 210 subjects.
